U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07091357) titled 'A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis' on July 21.
Brief Summary: This is a trial to evaluate the safety and efficacy of SHR-1819 injection in the treatment of patients with seasonal allergic rhinitis.
Study Start Date: Aug., 2025
Study Type: INTERVENTIONAL
Condition:
Seasonal Allergic Rhinitis
Intervention:
DRUG: SHR-1819 Injection
SHR-1819 injection.
DRUG: SHR-1819 Injection Placebo
SHR-1819 injection placebo.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Published by H...